Vaxneuvance (pneumococcal 15-valent conjugate vaccine) Patient Assistance Program
Don’t let the high cost of brand 15-valent pneumococcal conjugate vaccine disrupt your prevention. We help eligible patients access Vaxneuvance (pneumococcal 15-valent conjugate vaccine) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Vaxneuvance (PCV15) is FDA-approved for active immunization against invasive pneumococcal disease and pneumonia in adults ≥18 years and in pediatric patients ≥6 weeks. Contains polysaccharides from 15 pneumococcal serotypes conjugated to a carrier protein.
- Without assistance, Vaxneuvance costs commonly run approximately $200–$280 per dose.
- Through AffordMyPrescriptions, qualifying patients can access Vaxneuvance for a flat $69.95 per month.
- Other US pneumococcal vaccines: PCV20 (Prevnar 20 — newer, broader 20-serotype coverage), PCV13 (Prevnar 13 — older 13-valent), PPSV23 (Pneumovax 23 — 23-valent polysaccharide). ACIP recommendations for pneumococcal vaccination depend on age, immune status, and risk factors. Medicare Part B covers pneumococcal vaccines for beneficiaries with NO cost-share. ACA preventive coverage applies to many adults.
What Is Vaxneuvance Prescription Assistance Program?
Vaxneuvance PAP for pneumococcal vaccination patients.
Eligibility, primary care coordination.
AffordMyPrescriptions eliminates that burden. $69.95/month advocacy.
Pharmacy Price Comparison
- Vaxneuvance $200–$280/dose. Medicare Part B covers pneumococcal vaccines $0 cost-share for beneficiaries:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$260/dose | Save substantially |
| CVS Pharmacy | ~$280/dose | Save substantially |
| Walmart | ~$210/dose | Save substantially |
| Costco | ~$200/dose | Save substantially |
Medicare Part B | $0 | No cost-share |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Vaxneuvance Prescription Program?
PAP at no cost. Medicare Part B covers pneumococcal vaccines with no cost-share. ACA preventive coverage for many adults.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Vaxneuvance:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $200–$280 per dose per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Vaxneuvance assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Vaxneuvance Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Vaxneuvance:
Vaxneuvance is a 15-valent pneumococcal conjugate vaccine (PCV15) — covers 15 pneumococcal serotypes. Pneumococcal disease (invasive infection like meningitis/bacteremia, plus pneumonia) is a major cause of morbidity and mortality, especially in young children, elderly, and immunocompromised patients.
How Vaxneuvance Works:
Streptococcus pneumoniae causes pneumonia, otitis media, meningitis, bacteremia. Polysaccharide capsule is major virulence factor; antibodies to capsular polysaccharides confer protection.
PCV15 contains polysaccharides from 15 serotypes conjugated to a carrier protein (CRM197) — conjugation produces T-cell-dependent immune response with strong memory (vs. unconjugated PPSV23). Replaces or supplements older PCV13 in many adult and pediatric immunization schedules.
Form and use:
Vaxneuvance given as IM injection. Pediatric routine series at 2, 4, 6, and 12–15 months. Adult dosing varies by indication and prior pneumococcal vaccination history.
Generic availability:
No ‘generic.’ Pneumococcal vaccine alternatives: Prevnar 20 (PCV20 — broader coverage, increasingly preferred), Prevnar 13 (PCV13, older), Pneumovax 23 (PPSV23, polysaccharide). Current ACIP recommendations favor PCV20 for many adults; PCV15 if PCV20 unavailable, often followed by PPSV23. Discuss with provider about optimal pneumococcal vaccination strategy.
Warnings:
Common: injection site reactions, fatigue, headache, muscle ache. Rare severe reactions. Pregnant women: limited safety data with PCV15 specifically; PCV20 or other vaccines may have more data.
FAQ (Frequently Asked Questions)
Cost?
$200–$280/dose. Medicare Part B $0 cost-share. ACA preventive often $0. Insurance commercial may vary.
Vaxneuvance vs Prevnar 20?
Vaxneuvance (PCV15) covers 15 serotypes; Prevnar 20 (PCV20) covers 20 serotypes. Current ACIP recommendations generally prefer PCV20 if available for most adults. PCV15 acceptable; if used, typically followed by PPSV23 after 1+ year.
Need pneumococcal vaccine?
All children: routine series at 2/4/6/12–15 months. Adults: depends on age, prior vaccination, risk factors. Adults ≥65 generally recommended. Adults 19–64 with risk factors (chronic medical conditions, immunocompromise, CSF leak, cochlear implant, etc.) recommended.
Medicare Part B?
Yes — Medicare Part B covers pneumococcal vaccines (PCV20, PCV15, PPSV23) with $0 cost-share for beneficiaries. No out-of-pocket cost.
ACA preventive?
Most commercial insurance covers pneumococcal vaccines per ACIP recommendations with no cost-share under ACA preventive coverage.
PPSV23 after?
If you receive PCV15, ACIP recommends PPSV23 typically 1+ year later (8 weeks later for immunocompromised). If you receive PCV20, additional PPSV23 not routinely needed.
Denied?
Check insurance preventive coverage, Medicare Part B, or VFC for kids. PAP if uninsured.
Take Control of Your Medication Costs
If struggling with Vaxneuvance cost, we can help — or guide you to Medicare Part B coverage or insurance preventive coverage. Check eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.